Barron\'s - 16.09.2019

(backadmin) #1

M2 BARRON’S September 16, 2019


Thechartsrecordthenetchangeinshareprice,thehigh,lowandclosingtrades,andsharevolumeforcompanieswithnoteworthystockactivitylastweek.Inaddition,thegraphsdepictlastweek’sdailypriceactivityindetail.The


dottedlineonsomegraphsdenotesthestock’s200-daymovingaverage;lackofamovingaveragemeanstheshareshavetradedforlessthanthattimeperiod.


Charting the Market


A graphic look at selected stock activity for the week ended September 13, 2019nEdited by Bill Alpert


PROGRESSIVE


PGR (NYSE)•72.68•-4.71


70.5

72.5

74.5

MTWTF

76.5

78.5

56

62

68

74

80

86

Stock Price $

0

13

S O N D J F M A M J J AS

26

Volume in Millions

 Amid anxiety about


Hurricane Dorian’s dam-


age, the casualty insurer


reported lower earnings


and a higher loss ratio for


the month of August.


ZSCALER


ZS (NASD)•47.48•-16.57


45.5

50.5

55.5

MTWTF

60.5

65.5

19.0

33.5

48.0

62.5

77.0

91.5

Stock Price $

0

26

S O N D J F M A M J J AS

52

Volume in Millions

 Analysts chopped their


price targets for the cyber-


securityfirm’shighlyvalued


stock,afteritsaidthatdeals


weretakinglongertoclose.


Sales growth could slow.


WENDY'S


WEN (NASD)•19.42•-2.96


19

20

21

MTWTF

22

23

14

16

18

20

22

24

Stock Price $

0

21

S O N D J F M A M J J AS

42

Volume in Millions

Aplantoservebreakfast


next year will require


20,000 new workers, said


thefastfoodchain.Instead


of growing, its earnings in


2019 will fall 3.5%-to-6.5%.


BROADCOM


AVGO (NASD)•290.32•-1.59


281

287

293

MTWTF

299

305

206

230

254

278

302

326

Stock Price $

0

18

S O N D J F M A M J J AS

36

Volume in Millions

 July-quarter sales and


profits rose 9% at the chip


maker.Itsaidweakdemand


for its products had “bot-


tomedout,”butwarnedthat


aturnaroundwasn’tinsight.


FRANCESCA'S HOLDINGS


FRAN (NASD)•18.14•13.28


3.0

7.5

12.0

MTWTF

16.5

21.0

1

16

31

46

61

76

Stock Price $

0

21

S O N D J F M A M J J AS

42

Volume in Millions

 The struggling retailer


said July-quarter profits


rose to 61 cents a share,


fromtheyear-ago16cents—


despite a 6% drop in sales


on deeper markdowns.


AMERICAN RENAL ASSOCIATES HOLDINGS


ARA(NYSE)•9.81•2.01


7

9

11

MTWTF

13

15

5

9

13

17

21

25

Stock Price $

0

3

S O N D J F M A M J J AS

6

Volume in Millions

 The dialysis company re-


gained compliance with


NYSElistingrequirements,


afterrestatingfouryearsof


earnings to fix errors that


prompted an SEC inquiry.


MONGODB


MDB (NASD)•123.29•-17.34


119

125

131

MTWTF

137

143

40

70

100

130

160

190

Stock Price $

0

9

S O N D J F M A M J J AS

18

Volume in Millions

 The highflying stocks of


software firms like Mongo-


DB began losing favor


among investors, in a shift


towardvalue.Twilio,Okta,


and Trade Desk sank, too.


EXACT SCIENCES


EXAS (NASD)•106.71•-14.15


99

105

111

MTWTF

117

123

51

66

81

96

111

126

Stock Price $

0

13

S O N D J F M A M J J AS

26

Volume in Millions

 Investors were skeptical


of a $2.8 billion deal in


whichthevendorofcolorec-


talcancertestswillacquire


alineofbreastcancerdiag-


nostics, for cash and stock.


ADVERUM BIOTECHNOLOGIES


ADVM (NASD)•5.78•-6.34


3.0

5.5

8.0

MTWTF

10.5

13.0

2

5

8

11

14

17

Stock Price $

0

22

S O N D J F M A M J J AS

44

Volume in Millions

 Analysts were disap-


pointedbythemixedresults


of a clinical trial of the com-


pany’streatmentfortheeye


diseaseknownaswetage-re-


lated macular degeneration.


AURORA CANNABIS


ACB (NYSE)•5.95•-0.13


5.5

5.8

6.1

MTWTF

6.4

6.7

3

5

7

9

11

13

Stock Price $

0

165

S O N D J F M A M J J AS

330

Volume in Millions

 Sellingmorepotthanany


legalproducerinhistory,the


Canadian firm nevertheless


missed revenue targets and


lostmoneyinitsJunequar-


ter. It expects flat demand.


ACADIA PHARMACEUTICALS


ACAD (NASD)•40.45•16.65


35.0

37.5

40.0

MTWTF

42.5

45.0

11

18

25

32

39

46

Stock Price $

0

20

S O N D J F M A M J J AS

40

Volume in Millions

 An experimental drug


worked so well in treating


dementia-related psychosis


that Acadia is stopping its


Phase 3 trial early. It will


seek FDA approval in 2020.


TAILORED BRANDS


TLRD (NYSE)•5.10•-0.42


4

5

6

MTWTF

7

8

2.0

7.5

13.0

18.5

24.0

29.5

Stock Price $

0

22

S O N D J F M A M J J AS

44

Volume in Millions

 TheownerofMen’sWear-


house and Jos. A. Bank


clothingstoressaidsalesfell


4%intheJulyquarter.This


quartercouldseea5%drop,


andhalftheexpectedprofits.

Free download pdf